"At St. Luke's Clinic - Idaho Cardiology Associates, our team has over 150 years of combined experience in the treatment of heart disease and offers you comprehensive cardiovascular care. Clinic services include electrophysiology and arrhythmia exams and consultations, transthoracic and transesophageal echocardiograms, stress tests, and nuclear cardiology. We specialize in a wide range of procedures and interventions, including ablation, cardioversion, coronary angioplasty/stent, defibrillator implantation, heart catheterization, and pacemaker implantation. We also operate special clinics to focus on arrhythmias, pacemakers and defibrillators, anticoagulation, congestive heart failure, tobacco treatment, and lipid management."

During the past decade, Idaho Cardiology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Idaho Cardiology Associates" #1 sponsor was "Amgen" with 1 trials, followed by "Hartford Hospital" with 1 trials sponsored, "Midwest Heart Foundation" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Regado Biosciences, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Idaho Cardiology Associates" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Idaho Cardiology Associates" are "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome (ACS)" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Disease" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Idaho Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Idaho Cardiology Associates" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adenosine SPECT myocardial perfusion imaging" (1 trials), "Combined adenosine / exercise SPECT myocardial perfusion imaging" (1 trials), "Heparin" (1 trials), "Lp(a) Screening" (1 trials) and "REG1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Idaho Cardiology Associates" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Idaho Cardiology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Idaho Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Idaho Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".